Clinical Trial

PAI-1, tPA, TFPI and HEECs in Uterine Hemostasis

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated August 19, 2024 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of the study is to learn more about the role of blood clotting factor proteins and cells in menstrual (period) bleeding. The investigators are hoping to identify differences in these proteins and cells in the menstrual blood of individuals with heavy periods compared to menstruating individuals who do not have heavy periods.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-05-08; most recent amendment 2024-08-16.
Status change: Not Yet Recruiting → Recruiting 2023-07-18
Trial Details
NCT Number NCT05862805
Lead Sponsor Oregon Health and Science University
Conditions Menstrual Bleeding, Heavy
Enrollment 70 participants
Start Date 2023-07-12
Primary Completion 2025-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2024-08-19